Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis

Fig. 4

Network plot and forest plots from the network meta-analysis of HCC risk in CHB patients receiving different treatments. A Results of the total analysis. B Results of the subgroup analysis of patients with cirrhosis. C Results of the subgroup analysis of patients without cirrhosis. Control, no treatment or expectant treatment; ETV, Entecavir treatment; TDF, Tenofovir disoproxil fumarate treatment; Other NAs, Nucleos(t)ide Analogue treatments other than ETV and TDF (including Lamivudine, Telbivudine and Adefovir)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us